Suppr超能文献

PIAS1 调控的 SUMO 化修饰通路抑制 NMuMG 上皮细胞中 TGFβ 诱导的上皮-间充质转化样表型。

Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.

机构信息

Department of Biochemistry and Molecular Biology, Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada.

出版信息

PLoS One. 2010 Nov 12;5(11):e13971. doi: 10.1371/journal.pone.0013971.

Abstract

Epithelial-mesenchymal-transition (EMT) is a fundamental cellular process that is critical for normal development and tumor metastasis. The transforming growth factor beta (TGFβ) is a potent inducer of EMT like effects, but the mechanisms that regulate TGFβ-induced EMT remain incompletely understood. Using the widely employed NMuMG mammary epithelial cells as a model to study TGFβ-induced EMT, we report that TGFβ downregulates the levels of the SUMO E3 ligase PIAS1 in cells undergoing EMT. Gain and loss of function analyses indicate that PIAS1 acts in a SUMO ligase dependent manner to suppress the ability of TGFβ to induce EMT in these cells. We also find that TGFβ inhibits sumoylation of the PIAS1 substrate SnoN, a transcriptional regulator that antagonizes TGFβ-induced EMT. Accordingly, loss of function mutations of SnoN sumoylation impair the ability of SnoN to inhibit TGFβ-induced EMT in NMuMG cells. Collectively, our findings suggest that PIAS1 is a novel negative regulator of EMT and reveal that inhibition of the PIAS1-SnoN sumoylation pathway represents a key mechanism by which TGFβ induces EMT, with important implications in normal development and tumor metastasis.

摘要

上皮-间充质转化(EMT)是一种基本的细胞过程,对于正常发育和肿瘤转移至关重要。转化生长因子β(TGFβ)是 EMT 样效应的有效诱导剂,但调节 TGFβ 诱导的 EMT 的机制仍不完全清楚。我们使用广泛应用的 NMuMG 乳腺上皮细胞作为模型来研究 TGFβ 诱导的 EMT,报告 TGFβ 在发生 EMT 的细胞中下调 SUMO E3 连接酶 PIAS1 的水平。获得和丧失功能分析表明,PIAS1 以 SUMO 连接酶依赖的方式发挥作用,抑制 TGFβ 在这些细胞中诱导 EMT 的能力。我们还发现 TGFβ 抑制 PIAS1 底物 SnoN 的 sumoylation,SnoN 是一种转录调节剂,拮抗 TGFβ 诱导的 EMT。因此,SnoN sumoylation 的功能丧失突变会损害 SnoN 在 NMuMG 细胞中抑制 TGFβ 诱导的 EMT 的能力。总之,我们的发现表明 PIAS1 是 EMT 的一种新型负调节剂,并揭示了抑制 PIAS1-SnoN sumoylation 途径是 TGFβ 诱导 EMT 的关键机制,这对正常发育和肿瘤转移具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/662a/2980481/1e597ede4b0e/pone.0013971.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验